|
JP2007302644A
|
|
Gene expression inhibitor through ap-1 motif
|
|
JP2006169224A
|
|
Mrsa infection-alleviating dietary supplement
|
|
JP2005104946A
|
|
Inflammation suppressing substance originating from acanthopanax senticosus harms
|
|
JP2003095972A
|
|
Method for producing lipase inhibitor
|
|
JP2003034645A
|
|
Effective substance originated from periploca sepium bunge
|
|
JP2003026580A
|
|
Substitute for plasma
|
|
JPH07206892A
|
|
Oligonucleotide analog and medicine composition containing the same
|
|
JPH07149661A
|
|
Kallidinogenase-containing external preparation
|
|
JPH06179694A
|
|
Modified nucleic acid oligomer and antiviral agent containing the same
|
|
JPH05125103A
|
|
Production of hyaluronic acid
|
|
JPH07241200A
|
|
Production of hyaluronic acid
|
|
JPH03184973A
|
|
Protector against radiation injury
|
|
JPH0390032A
|
|
Production of mugwort leaf extract
|
|
JPH0366607A
|
|
Product for hygiene of oral cavity
|
|
JPH02255616A
|
|
Drug for hepatic disease
|
|
JPH02212401A
|
|
Method for preserving ingredient of plant body
|
|
JPH0232027A
|
|
Analgesic agent
|
|
JPH0232028A
|
|
Antitussive agent
|
|
JPH01319424A
|
|
Antipruritic agent
|
|
JPH01294627A
|
|
Drug for liver disease
|
